Measuring the impact of a continuing medical education program on patient blood pressure

Journal of Clinical Hypertension

Volumn 13, Issue 7, 2011, Pages 517-522

  Allaire, Benjamin T ^a   Trogdon, Justin G ^a   Egan, Brent M ^b   Lackland, Daniel T ^b   Masters, Dory ^c  

^a The Medical University of South Carolina ^*

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; HYPERTENSION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; DISEASE PROGRESSION; EDUCATION, MEDICAL, CONTINUING; EVIDENCE-BASED PRACTICE; FEMALE; HEALTH PERSONNEL; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEEDS ASSESSMENT; PATIENT CARE MANAGEMENT; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; SEVERITY OF ILLNESS INDEX; STAFF DEVELOPMENT;

EID: 79960443205     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2011.00469.x     Document Type: Article

References (23)

1. Ong K, Cheung B, Yan Y, et al. Prevalence, awareness, treatment and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75.
2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050.
3. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood pressure lowering treatment trialists collaboration. Lancet. 2000;356:1955-1964.
4. Kahn R, Robertson R, Smith R, et al. The impact of prevention on reducing the burden of cardiovascular disease. Circulation. 2008;118:575-585.
5. Schuster MA, McGlynn EA, Brook RH. How good is the quality of health care in the United States? Milbank Q. 1998;76:517-563.
6. Prior M, Guerin M, Grimmer-Somers K. The effectiveness of clinical guideline implementation strategies-a synthesis of systematic review findings. J Eval Clin Pract. 2008;14:888-897.
7. De Rivas B, Barrios V, Redon J, et al. Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study. J Clin Hypertens (Greenwich). 2010;12:335-344.
8. Bonds DE, Hogan PE, Bertoni AG, et al. A multifaceted intervention to improve blood pressure control: The Guideline Adherence for Heart Health (GLAD) study. Am Heart J. 2009;157:278-284.
9. Egan BM, Lackland DT, Igho-Pemu P, et al. Cardiovascular risk factor control in communities-Update from the ASH Carolinas-Georgia Chapter, the hypertension initiative, and the community physicians' network. J Clin Hypertens (Greenwich). 2006;8:879-886.
10. Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
11. Caliendo M, Kopeinig S. Some practical guidance for the implementation of propensity score matching. J Econ Surv. 2008;22:31-72.
12. Dehejia R. Practical propensity score matching: a reply to Smith and Todd. J Econom. 2005;125:355-364.
13. Stata Statistical Software: Release 10.1 [computer program]. College Station, TX: Statacorp LP; 2008.
14. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing [computer program]. Version 3.1.4: Leuven, E., Sianesi, B.; 2003.
15. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
16. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342:1317-1322.
17. Simon SR, Majumdar SR, Prosser LA, et al. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. Am J Med. 2005;118:521-528.
18. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10.
19. Streppel MT, Arends LR, van 't Veer P, et al. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165:150-156.
20. Stamler R. Implications of the INTERSALT study. Hypertension. 1991;17(suppl 1):I16-I20.
21. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888.
22. Cook N, Cohen J, Hebert P, et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155:701-709.
23. Behavioral Risk Factor Surveillance System. Prevalence and trends data, South Carolina-2007, hypertension awareness. Accessed March 3, 2009.